References
1. Toth NK, Csanadi Z, Hajas O, et al.
Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with
Atrial Fibrillation. 2017;2017:3678017.
2. Cove CL, Albert CM, Andreotti F,
Badimon L, Van Gelder IC, Hylek EM. Female sex as an independent risk
factor for stroke in atrial fibrillation: possible mechanisms.Thrombosis and haemostasis. 2014;111(3):385-391.
3. Kirchhof P, Benussi S, Kotecha D,
et al. 2016 ESC Guidelines for the management of atrial fibrillation
developed in collaboration with EACTS. European Heart Journal.2016;37(38):2893-2962.
4. January CT, Wann LS, Calkins H, et
al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline
for the Management of Patients With Atrial Fibrillation: A Report of the
American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines and the Heart Rhythm Society in
Collaboration With the Society of Thoracic Surgeons. Circulation.2019;140(2):e125-e151.
5. Litwinowicz R, Bartus M,
Malec-Litwinowicz M, et al. Left Atrial Appendage Occlusion for
Secondary Stroke Prevention in Patients with Atrial Fibrillation:
Long-Term Results. Cerebrovascular Diseases. 2019:1-8.
6. Bajaj NS, Parashar A, Agarwal S, et
al. Percutaneous left atrial appendage occlusion for stroke prophylaxis
in nonvalvular atrial fibrillation: a systematic review and analysis of
observational studies. JACC Cardiovascular interventions.2014;7(3):296-304.
7. Whitlock R, Healey J, Vincent J, et
al. Rationale and design of the left atrial appendage occlusion study
(LAAOS) III. Annals of cardiothoracic surgery. 2014;3(1):45.
8. Litwinowicz R, Bartus M, Burysz M,
et al. Long term outcomes after left atrial appendage closure with the
LARIAT device—Stroke risk reduction over five years follow-up.PloS one. 2018;13(12):e0208710.
9. Litwinowicz R, Bartus M, Ceranowicz
P, et al. Left atrial appendage occlusion for stroke prevention in
diabetes mellitus patients with atrial fibrillation: Long-term results.Journal of diabetes. 2019;11(1):75-82.
10. Litwinowicz R, Bartus M,
Ceranowicz P, Kapelak B, Lakkireddy D, Bartus K. Stroke risk reduction
after left atrial appendage occlusion in elderly patients with atrial
fibrillation: longterm results. Polish archives of internal
medicine. 2018;128(5):327-329.
11. Suwalski P, Witkowska A,
Drobiński D, et al. Stand-alone totally thoracoscopic left atrial
appendage exclusion using a novel clipping system in patients with high
risk of stroke–initial experience and literature review.Kardiochirurgia i torakochirurgia polska= Polish journal of
cardio-thoracic surgery. 2015;12(4):298.
12. Mills JD, Ariens RA, Mansfield
MW, Grant PJ. Altered fibrin clot structure in the healthy relatives of
patients with premature coronary artery disease. Circulation.2002;106(15):1938-1942.
13. Pieters M, Philippou H, Undas A,
et al. An international study on the feasibility of a standardized
combined plasma clot turbidity and lysis assay: communication from the
SSC of the ISTH. Journal of Thrombosis and Haemostasis.2018;16(5):1007-1012.
14. Hemker HC. Thrombin generation in
a reconstituted system: a comment. Thrombosis and haemostasis.2002;87:551-554.
15. Kirchhof P, Benussi S, Kotecha D,
et al. 2016 ESC Guidelines for the management of atrial fibrillation
developed in collaboration with EACTS. European heart journal.2016;37(38):2893-2962.
16. Blackshear JL, Odell JA.
Appendage obliteration to reduce stroke in cardiac surgical patients
with atrial fibrillation. The Annals of thoracic surgery.1996;61(2):755-759.
17. Di Biase L, Santangeli P,
Anselmino M, et al. Does the left atrial appendage morphology correlate
with the risk of stroke in patients with atrial fibrillation? Results
from a multicenter study. Journal of the American College of
Cardiology. 2012;60(6):531-538.
18. Mitusch R, Siemens HJ, Garbe M,
Wagner T, Sheikhzadeh A, Diederich KW. Detection of a hypercoagulable
state in nonvalvular atrial fibrillation and the effect of anticoagulant
therapy. Thrombosis and haemostasis. 1996;75(2):219-223.
19. Califano F, Giovanniello T,
Pantone P, et al. Clinical importance of thrombomodulin serum levels.European review for medical and pharmacological sciences.2000;4(3):59-66.
20. Zabczyk M, Majewski J, Lelakowski
J. Thromboembolic events are associated with prolonged clot lysis time
in patients with permanent atrial fibrillation. Polskie Archiwum
Medycyny Wewnetrznej. 2011;121(11):400-407.
21. Adams TE, Huntington JA.
Thrombin-cofactor interactions: structural insights into regulatory
mechanisms. Arteriosclerosis, thrombosis, and vascular biology.2006;26(8):1738-1745.
22. Drabik L, Wolkow P, Undas A.
Denser plasma clot formation and impaired fibrinolysis in paroxysmal and
persistent atrial fibrillation while on sinus rhythm: association with
thrombin generation, endothelial injury and platelet activation.Thrombosis research. 2015;136(2):408-414.
23. Roldan V, Marin F, Marco P,
Martinez JG, Calatayud R, Sogorb F. Hypofibrinolysis in atrial
fibrillation. American heart journal. 1998;136(6):956-960.
24. Camm AJ, Lip GY, De Caterina R,
et al. 2012 focused update of the ESC Guidelines for the management of
atrial fibrillation: an update of the 2010 ESC Guidelines for the
management of atrial fibrillation. Developed with the special
contribution of the European Heart Rhythm Association. European
heart journal. 2012;33(21):2719-2747.
25. Litwinowicz R, Bartus M,
Ceranowicz P, et al. Left atrial appendage occlusion for stroke
prevention in diabetes mellitus patients with atrial fibrillation:
Long-term results. Journal of diabetes. 2018.
26. Litwinowicz R, Bartus M,
Ceranowicz P, Kapelak B, Lakkireddy D, Bartus K. Stroke risk reduction
after LAA occlusion in elderly patients with atrial fibrillation:
long-term results. Pol Arch Intern Med. 2018.
27. Wiebe J, Franke J, Lehn K, et al.
Percutaneous Left Atrial Appendage Closure With the Watchman Device:
Long-Term Results Up to 5 Years. JACC Cardiovascular
interventions. 2015;8(15):1915-1921.
28. Bartus K, Morelli RL, Szczepanski
W, Kapelak B, Sadowski J, Lee RJ. Anatomic analysis of the left atrial
appendage after closure with the LARIAT device. Circulation
Arrhythmia and electrophysiology. 2014;7(4):764-767.
29. Litwinowicz R, Bartus M, Kapelak
B, et al. Reduction in risk of stroke and bleeding after left atrial
appendage closure with LARIAT device in patients with increased risk of
stroke and bleeding: Long term results. Catheterization and
Cardiovascular Interventions. 2019.
30. Burysz M, Litwinowicz R, Bryndza
M, Skowronek R, Ogorzeja W, Bartus K. Percutaneous left atrial appendage
closure using the LAmbre device. First clinical results in Poland.Advances in Interventional Cardiology/Postępy w Kardiologii
Interwencyjnej. 2019;15(2):251-254.
Table 1. Patient characteristics